Cryoport, Inc.CYRXEarnings & Financial Report
Cryoport, Inc. is a global provider of specialized temperature-controlled logistics and supply chain solutions focused on the life sciences, biopharmaceutical, and cell and gene therapy sectors. It partners with research institutions, biotech firms, and pharmaceutical manufacturers globally to support the safe transport of sensitive biological materials including clinical trial samples and advanced therapy products.
Revenue
$44.2M
Gross Profit
$21.3M
Operating Profit
$-9.9M
Net Profit
$-6.9M
Gross Margin
48.2%
Operating Margin
-22.5%
Net Margin
-15.7%
YoY Growth
15.4%
EPS
$-0.18
Cryoport, Inc. Q3 FY2025 Financial Summary
Cryoport, Inc. reported revenue of $44.2M (up 15.4% YoY) for Q3 FY2025, with a net profit of $-6.9M (down 962.5% YoY) (-15.7% margin). Cost of goods sold was $22.9M, operating expenses totaled $31.3M.
Key Financial Metrics
| Total Revenue | $44.2M |
|---|---|
| Net Profit | $-6.9M |
| Gross Margin | 48.2% |
| Operating Margin | -22.5% |
| Report Period | Q3 FY2025 |
Revenue Breakdown
Cryoport, Inc. Q3 FY2025 revenue of $44.2M breaks down across 3 segments, led by Products at $20.0M (45.2% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Products | $20.0M | 45.2% |
| Biologistics Solutions | $19.4M | 43.9% |
| Biostorage Bioservices | $4.8M | 10.9% |
Cryoport, Inc. Revenue by Segment — Quarterly Trend
Cryoport, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Products and Biologistics Solutions) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Products | — | $20.0M | $21.1M | — |
| Biologistics Solutions | — | $19.4M | — | $18.5M |
| Biostorage Bioservices | — | $4.8M | $4.5M | $4.3M |
Cryoport, Inc. Annual Revenue by Year
Cryoport, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $176.2M).
| Year | Annual Revenue |
|---|---|
| 2025 | $176.2M |
| 2024 | $156.8M |
| 2023 | $168.7M |
| 2022 | $237.3M |
Cryoport, Inc. Quarterly Revenue & Net Profit History
Cryoport, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $45.5M | +9.6% | $-8.0M | -17.5% |
| Q3 FY2025 | $44.2M | +15.4% | $-6.9M | -15.7% |
| Q2 FY2025 | $45.5M | +14.5% | $105.2M | 231.4% |
| Q1 FY2025 | $41.0M | +10.1% | $-12.0M | -29.2% |
| Q4 FY2024 | $41.5M | +665.3% | $-18.7M | -45.1% |
| Q3 FY2024 | $38.3M | -31.8% | $805.0K | 2.1% |
| Q2 FY2024 | $39.7M | -30.4% | $-78.0M | -196.4% |
| Q1 FY2024 | $37.3M | -40.6% | $-18.9M | -50.7% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $37.3M | $39.7M | $38.3M | $41.5M | $41.0M | $45.5M | $44.2M | $45.5M |
| YoY Growth | -40.6% | -30.4% | -31.8% | 665.3% | 10.1% | 14.5% | 15.4% | 9.6% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $942.8M | $852.3M | $701.8M | $703.5M | $699.8M | $773.9M | $774.3M | $765.0M |
| Liabilities | $470.7M | $452.2M | $283.2M | $301.6M | $301.0M | $258.5M | $261.1M | $262.4M |
| Equity | $472.2M | $400.1M | $418.6M | $401.9M | $398.8M | $519.1M | $513.3M | $502.6M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-3.3M | $-8.0M | $447000 | $-5.5M | $-4.3M | $-7.3M | $2.2M | $919000 |